LATE-BREAKING ABSTRACT: The effect of temperature during sputum processing on inflammatory markers

Q. Zhang, N. Li, M. He, M. Feng, J. Li (Guangzhou, China)

Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Session: Systemic and airway biomarkers in respiratory diseases
Session type: Thematic Poster Session
Number: 827
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Q. Zhang, N. Li, M. He, M. Feng, J. Li (Guangzhou, China). LATE-BREAKING ABSTRACT: The effect of temperature during sputum processing on inflammatory markers. Eur Respir J 2013; 42: Suppl. 57, 827

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: Surfactant protein D is dysregulated in severe asthma
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014


LATE-BREAKING ABSTRACT: Critical role of proton-sensing OGR1 in dendritic cells in development of asthma
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014

LATE-BREAKING ABSTRACT: Phosphoinositide-dependent protein kinase-1 mediates inhibitory effects on eosinophils.
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014



LATE-BREAKING ABSTRACT: A phase 2 study of benralizumab on exacerbations, lung function, and asthma control in adults with uncontrolled eosinophilic asthma
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014


Blood cytotoxic/pro-inflammatory mediators in severe asthma
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014

LATE-BREAKING ABSTRACT: The CCR4 Antagonist CCX6239 for the treatment of allergic airways disease
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013

LATE-BREAKING ABSTRACT: IL-5-induced airways eosinophilia as a negative regulator of TLR7 expression may impair the interferon response to rhinovirus in allergic airways
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014


LATE-BREAKING ABSTRACT: "Capsaicin-induced bronchoconstriction in passive sensitized human precision-cut lung slices is mast cell dependent"
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014

LATE-BREAKING ABSTRACT: p-STAT6 and PU.1 are involved in IL-9 production by Th9 cells during allergen-induced late phase airway inflammation in asthma patients
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014

LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma.
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014

LATE-BREAKING ABSTRACT: T-cell membrane organization as a potential new target in asthma
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015

LATE-BREAKING ABSTRACT: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Year: 2015


Fungal sensitization in patients with moderate and severe asthma
Source: International Congress 2014 – Clinical allergy
Year: 2014


LATE-BREAKING ABSTRACT: Impact of demographics and comorbidities on periostin and eosinophil levels
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016


Investigating airway HMGB1 redox state in health and asthma
Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Year: 2014

Altered airway microbiome in stable asthma
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014


LATE-BREAKING ABSTRACT: Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting the allergen-induced early asthmatic response
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014


LATE-BREAKING ABSTRACT: TSLP as a potent activator of Th2 response in obstructive lung diseases
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016


Immune modulation of the T-cell response in asthma through Wnt10b
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014

LATE-BREAKING ABSTRACT: Using eosinophilic phenotype to characterize asthma control.
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014